deltatrials
Unknown PHASE1 INTERVENTIONAL 1-arm NCT06200376

A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer

A Clinical Study of Safety and Efficacy of T3011 Administered Via Intraperitoneal Injection as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer

Sponsor: West China Hospital

Conditions Malignant Ascites
Interventions T3011
Updated 4 times since 2024 Last updated: Dec 27, 2023 Started: Sep 28, 2023 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Malignant Ascites and is currently ongoing. West China Hospital leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshotRecruiting~Jan 2026 – present · 5 months · monthly snapshotUnknown

Change History

4 versions recorded

  1. Jan 2026 — Present [monthly]

    Unknown PHASE1

    Status: Recruiting → Unknown

  2. Sep 2024 — Jan 2026 [monthly]

    Recruiting PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  4. Feb 2024 — Jul 2024 [monthly]

    Recruiting PHASE1

    First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • West China Hospital
Data source: West China Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations